Analyst
KeyBank
Equibles does not estimate personal net worth.
Brett Fishman is recorded as Analyst at KeyBank. Brett Fishman has spoken on 5 earnings calls across 5 companies, most recently for Lemaitre Vascular Inc on November 4, 2026. Those appearances were for Lemaitre Vascular Inc (LMAT), Ufp Technologies Inc (UFPT), Sotera Health Co (SHC), STERIS plc (STE) and Integer Holdings Corp (ITGR). The companies whose calls Brett Fishman spoke on are classified in the Healthcare sector.
“Just maybe one or two on the deep run acquisition. Understand the 18 to 24 month transfer phase, and it makes sense. But just thinking about inorganic modeling for next year, maybe like any flavor for how far along you expect to be next year in aggregate as a proportion of the total sales.”
“Now, I wanted to just ask on AJR, and I know you guys are progressing in moving some of the product lines offshore, not quite done.”
“Just maybe moving past the segment conversation, I think at a high level, you noted that revenue from the cross-selling or XBU customer base was up 9% year over year in 2025.”
“Just was hoping maybe at a high level, you know, company-wide, you could just touch on how you're thinking about, you know, fourth quarter constant currency growth.”
“You can hit on the specific headwinds in a second. We're just curious, you know, the green bar that's, you know, related to rest of portfolio organic growth is four to seven percent.”
KeyBank
Analyst
Transcript header (unverified)
Medical Instruments & Supplies · Healthcare
UFPT
Medical Devices · Healthcare
SHC
Diagnostics & Research · Healthcare
STE
Medical Devices · Healthcare
